Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
ILM1k | Xetra | EUR | Delayed | |
ILM1k | TradeGate | EUR | Delayed | |
ILM1k | Frankfurt | EUR | Delayed |
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, parenteral nutrition solutions, and investigational medicinal products. Medios AG was founded in 2016 and is headquartered in Berlin, Germany.
Name | Age | Since | Title |
---|---|---|---|
Joachim Messner | 61 | 2016 | Vice Chairman of Supervisory Board |
Klaus J. Buß | 60 | 2016 | Member of Supervisory Board |
Yann Samson | 51 | - | Chairman of Supervisory Board & Sustainability Officer |
Anke Nestler | 55 | 2021 | Deputy Chairwoman of the Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review